Table 50.1Cost and Effectiveness Data for Vision and Hearing Care Interventions

ConditionInterventionCost data (2004 US$)Effectiveness dataIncremental cost-effectiveness data (2004 US$/DALY averted)
TrachomaTrichiasis surgery7.14 per village-based surgerya77 percent cure rate over two yearsb4–82c
Tetracycline51 percent cure rate in children at six months following treatmentd>9,600d
Azithromycin88 percent cure rate in children at six months following treatmente>4,100d
CataractExtracapsular surgery<200 (low- and middle-income countries); <2,400 (high-income countries)b
OnchocerciasisIvermectin40f

Source: Authors.

— = not available.

c. Baltussen and others (2005). Cost-effectiveness calculations are based on data from Frick and others (2001) for mass treatment of children only, not greater efficacy reported by Bowman and others (2000) and Solomon and others (2004) for mass treatment of entire communities. The greater efficacy reported in mass treatment of entire communities may lead to better cost-effectiveness.

From: Chapter 50, Loss of Vision and Hearing

Cover of Disease Control Priorities in Developing Countries
Disease Control Priorities in Developing Countries. 2nd edition.
Jamison DT, Breman JG, Measham AR, et al., editors.
Washington (DC): World Bank; 2006.
Copyright © 2006, The International Bank for Reconstruction and Development/The World Bank Group.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.